Instil Bio, Inc. Profile Avatar - Palmy Investing

Instil Bio, Inc.

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline includ…

Biotechnology
US, Dallas [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of TIL's Analysis
CIK: 1789769 CUSIP: 45783C101 ISIN: US45783C2008 LEI: - UEI: -
Secondary Listings
TIL has no secondary listings inside our databases.